Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China · Delayed Price · Currency is CNY 21.87
+0.39 (1.82%)
May 22, 2026, 3:00 PM CST
SHA:605033 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 54.33 | 48.66 | 36.86 | 57.56 | 145.09 | 125.74 |
Depreciation & Amortization | 32.64 | 32.64 | 20.43 | 20.87 | 15.47 | 12.48 |
Other Amortization | 0.25 | 0.25 | 1.92 | 0.35 | 0.35 | 0.07 |
Asset Writedown & Restructuring Costs | 20.39 | 20.39 | 0.03 | 0.04 | 0.12 | 0.02 |
Loss (Gain) From Sale of Investments | -6.32 | -6.32 | -8.23 | -4.58 | -4.04 | -0.91 |
Provision & Write-off of Bad Debts | - | - | -5.24 | -2.47 | 5.99 | 3.65 |
Other Operating Activities | -45.96 | -1.43 | 19.83 | 16.49 | 8.19 | 13.65 |
Change in Accounts Receivable | 16.78 | 16.78 | 66.49 | 98.49 | -57.22 | -105.49 |
Change in Inventory | 11.74 | 11.74 | 67.59 | 85.48 | 92.31 | -293.91 |
Change in Accounts Payable | 103.29 | 103.29 | 80.15 | 67.44 | -71.9 | 135.81 |
Operating Cash Flow | 190.5 | 229.36 | 280.4 | 334.79 | 126.41 | -108.75 |
Operating Cash Flow Growth | -0.86% | -18.20% | -16.25% | 164.84% | - | - |
Capital Expenditures | -173.52 | -184.63 | -158.81 | -203.69 | -109.29 | -106.53 |
Sale of Property, Plant & Equipment | 1.36 | 1.35 | 0.01 | - | 0.03 | - |
Investment in Securities | -30 | -37 | -388 | 80 | 68 | -148 |
Other Investing Activities | 8.57 | 7.88 | 9.33 | 6.51 | 6.86 | 2.61 |
Investing Cash Flow | -193.6 | -212.39 | -537.47 | -117.18 | -34.4 | -251.92 |
Short-Term Debt Issued | - | - | - | - | 40 | 204.04 |
Long-Term Debt Issued | - | 78 | 73 | 2.07 | - | - |
Total Debt Issued | 158 | 78 | 73 | 2.07 | 40 | 204.04 |
Short-Term Debt Repaid | - | - | - | - | -67.05 | -177 |
Long-Term Debt Repaid | - | -0.49 | -1 | -1.07 | - | - |
Total Debt Repaid | -73 | -0.49 | -1 | -1.07 | -67.05 | -177 |
Net Debt Issued (Repaid) | 85 | 77.51 | 72 | 1 | -27.05 | 27.04 |
Issuance of Common Stock | - | - | - | - | 25.57 | 391.84 |
Repurchase of Common Stock | - | - | - | -25.91 | - | - |
Common Dividends Paid | -24.49 | -24.09 | -28.24 | -29.82 | -26.67 | -3.29 |
Other Financing Activities | 22.05 | -24.1 | -18.91 | -3.68 | 69.99 | -65 |
Financing Cash Flow | 82.55 | 29.32 | 24.85 | -58.42 | 41.84 | 350.59 |
Foreign Exchange Rate Adjustments | -0 | -0 | - | - | - | 0.06 |
Net Cash Flow | 79.45 | 46.28 | -232.22 | 159.2 | 133.85 | -10.02 |
Free Cash Flow | 16.97 | 44.74 | 121.59 | 131.1 | 17.12 | -215.28 |
Free Cash Flow Growth | -42.51% | -63.21% | -7.26% | 665.68% | - | - |
Free Cash Flow Margin | 1.77% | 4.91% | 13.73% | 18.75% | 1.89% | -25.55% |
Free Cash Flow Per Share | 0.13 | 0.33 | 0.89 | 0.98 | 0.13 | -1.95 |
Cash Income Tax Paid | 3.9 | 3.79 | 13.33 | 15.85 | 26.36 | 19.05 |
Levered Free Cash Flow | -130.83 | 11.06 | 180.84 | 132.4 | -48.62 | -303.49 |
Unlevered Free Cash Flow | -130.83 | 11.06 | 180.85 | 132.64 | -48 | -301.43 |
Change in Working Capital | 135.15 | 135.15 | 214.79 | 246.54 | -44.75 | -263.45 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.